Viral Genetics, Inc. (Pink VRAL): is a biotechnology R&D company researching new treatments and methods of detection for HIV/AIDS, Lyme Disease, staph and strep, cancer and certain other autoimmune and infectious diseases. Two approaches based on patent rights licensed from the University of Colorado and University of Vermont form the basis of our research: “Targeted Peptides” and “Metabolic Disruption”. As we near completion of our preclinical research, we are preparing pre-IND applications for FDA clinical trials of compounds from these approaches in the US. We also have a subsidiary called VG Energy that is separately developing the non-disease applications of our metabolic technology.
Website: viralgenetics.com |
